Recovered heart failure with reduced ejection fraction and outcomes: a prospective study
- PMID: 28387002
- DOI: 10.1002/ejhf.824
Recovered heart failure with reduced ejection fraction and outcomes: a prospective study
Abstract
Aims: Significant recovery of left ventricular ejection fraction (LVEF) occurs in a proportion of patients with heart failure (HF) and reduced ejection fraction (HFrEF). We analysed outcomes, including mortality [all-cause, cardiovascular (CV), HF-related, and sudden death], and HF-related hospitalizations in this HF-recovered group. The primary endpoint was a composite of CV death or HF hospitalization.
Methods and results: LVEF was assessed at baseline and at 1 year in 1057 consecutive HF patients. Patients were classified into three groups: (i) HF-recovered: LVEF <45% at baseline and ≥45% at 1 year (n = 233); (ii) HF with preserved EF (HFpEF): LVEF ≥45% throughout follow-up (n = 117); and (iii) HFrEF: LVEF <45% throughout follow-up (n = 707). Mean follow-up was 5.6 ± 3.1 years. HF-recovered patients differed from HFrEF and HFpEF groups in demographic and clinical characteristics. The mean LVEF increase was 21.1 ± 10 points in HF-recovered patients. Using the HF-recovered group as a reference, the risks for the primary composite endpoint (n = 376), with non-CV death as competing risk, for HFpEF and HFrEF groups were: hazard ratio (HR) 2.33 [95% confidence interval (CI) 1.60-3.39], P < 0.001 and HR 1.99 (95% CI 1.50-2.65), P < 0.001, respectively. All-cause (n = 429), CV (n = 245), HF-related (n = 127), and sudden death (n = 60) were significantly lower in HF-recovered subjects relative to HFrEF (all P < 0.01). HF-recovered patients also experienced less recurrent HF hospitalizations (P < 0.001).
Conclusion: One in four treated patients with HFrEF showed recovery of systolic function. HF-recovered patients had significantly improved mortality and morbidity relative to HFpEF and HFrEF subjects. Further research is needed to identify optimal medications and device indications for HF-recovered patients.
Keywords: Heart failure with mid-range ejection fraction; Heart failure with preserved ejection fraction; Heart failure with reduced ejection fraction; Left ventricular ejection fraction; Recovered.
© 2017 The Authors. European Journal of Heart Failure © 2017 European Society of Cardiology.
Similar articles
-
Heart failure with recovered ejection fraction: Clinical characteristics, determinants and prognosis. CARDIOCHUS-CHOP registry.Cardiol J. 2018;25(3):353-362. doi: 10.5603/CJ.a2017.0103. Epub 2017 Oct 5. Cardiol J. 2018. PMID: 28980289
-
Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes.Circ Heart Fail. 2016 Apr;9(4):e002826. doi: 10.1161/CIRCHEARTFAILURE.115.002826. Circ Heart Fail. 2016. PMID: 27009553 Free PMC article.
-
Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain).BMJ Open. 2017 Dec 21;7(12):e018719. doi: 10.1136/bmjopen-2017-018719. BMJ Open. 2017. PMID: 29273666 Free PMC article.
-
Sudden death in heart failure with preserved ejection fraction and beyond: an elusive target.Heart Fail Rev. 2019 Nov;24(6):847-866. doi: 10.1007/s10741-019-09804-2. Heart Fail Rev. 2019. PMID: 31147814 Review.
-
Atrial fibrillation and risk of adverse outcomes in heart failure with reduced, mildly reduced, and preserved ejection fraction: A systematic review and meta-analysis.J Cardiovasc Electrophysiol. 2024 Apr;35(4):715-726. doi: 10.1111/jce.16209. Epub 2024 Feb 13. J Cardiovasc Electrophysiol. 2024. PMID: 38348517
Cited by
-
Development and Validation of a Nomogram Model for Predicting the Risk of Readmission in Patients with Heart Failure with Reduced Ejection Fraction within 1 Year.Cardiovasc Ther. 2022 Sep 16;2022:4143173. doi: 10.1155/2022/4143173. eCollection 2022. Cardiovasc Ther. 2022. PMID: 36186488 Free PMC article. Clinical Trial.
-
Potential Prognostic Relevance of Left-Ventricular Global Longitudinal Strain and of the Summation of the Mitral and Tricuspid Regurgitation Volume in Patients with Non-Ischemic Dilated Cardiomyopathy.J Cardiovasc Dev Dis. 2023 Sep 27;10(10):410. doi: 10.3390/jcdd10100410. J Cardiovasc Dev Dis. 2023. PMID: 37887857 Free PMC article.
-
The contribution of comorbidities to mortality in hospitalized patients with heart failure.Clin Res Cardiol. 2018 Jun;107(6):487-497. doi: 10.1007/s00392-018-1210-x. Epub 2018 Feb 5. Clin Res Cardiol. 2018. PMID: 29404680
-
Beta-blockers are associated with reverse remodeling in patients with dilated cardiomyopathy and mid-range ejection fraction.Am Heart J Plus. 2021 Oct 7;11:100053. doi: 10.1016/j.ahjo.2021.100053. eCollection 2021 Nov. Am Heart J Plus. 2021. PMID: 38559320 Free PMC article.
-
GENERATOR HEART FAILURE DataMart: An integrated framework for heart failure research.Front Cardiovasc Med. 2023 Mar 22;10:1104699. doi: 10.3389/fcvm.2023.1104699. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37034335 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous